AFP and hepatocellular carcinoma: Elevated AFP levels have demonstrated predictive value for various clinical outcomes, including tumor recurrence after resection [90], risk of drop-out in patients awaiting liver transplantation [91], survival rates [89], response to loco-regional therapies [92], and overall survival in advanced HCC [89].